Log in
NYSE:GSK

GlaxoSmithKline Stock Forecast, Price & News

$37.07
-0.16 (-0.43 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$36.85
Now: $37.07
$37.21
50-Day Range
$33.42
MA: $36.50
$39.17
52-Week Range
$31.43
Now: $37.07
$48.25
Volume2.80 million shs
Average Volume4.03 million shs
Market Capitalization$92.99 billion
P/E Ratio11.41
Dividend Yield5.24%
Beta0.63
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Read More
GlaxoSmithKline logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-8047-5000
Employees99,437

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$43.10 billion
Cash Flow$4.39 per share
Book Value$10.62 per share

Profitability

Net Income$5.93 billion

Miscellaneous

Outstanding Shares2,508,520,000
Market Cap$92.99 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$37.07
-0.16 (-0.43 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GlaxoSmithKline (NYSE:GSK) Frequently Asked Questions

How has GlaxoSmithKline's stock price been impacted by Coronavirus (COVID-19)?

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GSK shares have decreased by 7.0% and is now trading at $37.07.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of GlaxoSmithKline?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 2 sell ratings, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for GlaxoSmithKline
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than GlaxoSmithKline?

Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for GlaxoSmithKline
.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (NYSE:GSK) announced its quarterly earnings data on Wednesday, October, 28th. The pharmaceutical company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.14. The pharmaceutical company had revenue of $11.17 billion for the quarter, compared to analysts' expectations of $11.27 billion. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%.
View GlaxoSmithKline's earnings history
.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline declared a quarterly dividend on Thursday, October 29th. Stockholders of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. This represents a $1.98 dividend on an annualized basis and a yield of 5.35%. The ex-dividend date of this dividend is Thursday, November 12th. This is an increase from GlaxoSmithKline's previous quarterly dividend of $0.49.
View GlaxoSmithKline's dividend history
.

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the following people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 50)
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 58)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 57)
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 59)
  • Ms. Sarah Elton-Farr, Head of Investor Relations
  • Mr. Nick Hirons, Sr. VP of Global Ethics & Compliance
  • Mr. James Ford, Sr. VP & Gen. Counsel
  • Ms. Sally Jackson, Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad, Sr. VP of HR
  • Mr. David Simon Redfern, Chief Strategy Officer (Age 54)

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

Who are GlaxoSmithKline's major shareholders?

GlaxoSmithKline's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (0.65%), State Street Corp (0.37%), Black Creek Investment Management Inc. (0.26%), Boston Partners (0.23%), Arrowstreet Capital Limited Partnership (0.16%) and Morgan Stanley (0.13%).
View institutional ownership trends for GlaxoSmithKline
.

Which major investors are selling GlaxoSmithKline stock?

GSK stock was sold by a variety of institutional investors in the last quarter, including Camber Capital Management LP, UBS Asset Management Americas Inc., BlackRock Inc., Federated Hermes Inc., OLD Mission Capital LLC, Boston Partners, Arrowstreet Capital Limited Partnership, and Brandes Investment Partners LP.
View insider buying and selling activity for GlaxoSmithKline
.

Which major investors are buying GlaxoSmithKline stock?

GSK stock was acquired by a variety of institutional investors in the last quarter, including Black Creek Investment Management Inc., Galibier Capital Management Ltd., Voloridge Investment Management LLC, Fisher Asset Management LLC, First Trust Advisors LP, Douglas Lane & Associates LLC, Holloway Wealth Management LLC, and Clark Estates Inc. NY.
View insider buying and selling activity for GlaxoSmithKline
.

How do I buy shares of GlaxoSmithKline?

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately $37.07.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of $92.99 billion and generates $43.10 billion in revenue each year. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. GlaxoSmithKline employs 99,437 workers across the globe.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is www.gsk.com.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.